Selection of CD34⁺ Cells from Cryopreserved PBPC can be Significantly Improved by the Addition of Recombinant Human DNase (Pulmozyme)

By Alcorn MJ   Richmond LJ   Farrell E   Barr J   Pearson C   Schupp R   Franklin IM  

Cytotherapy, Vol. 1, Iss. 1, 1999-01 ,pp. : 31-40

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Viability and engraftment of hematopoietic progenitor cells after long-term cryopreservation: effect of diagnosis and percentage dimethyl sulfoxide concentration

By Veeraputhiran Muthu   Theus John W.   Pesek Gina   Barlogie Bart   Cottler-Fox Michele  

Cytotherapy, Vol. 12, Iss. 6, 2010-10 ,pp. : 764-766

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Viability of cryopreserved BM progenitor cells stored for more than a decade

By Donnenberg AD   Koch EK   Griffin DL   Stanczak HM   Kiss JE   Carlos TM   Buchbarker DM   Yeager AM  

Cytotherapy, Vol. 4, Iss. 2, 2002-03 ,pp. : 157-163

Ashgate Publishing Ltd

Access to resources Recommend Favorite

CD34⁺ cell enrichment depletes atypical CD30⁺ cells from PBPC grafts in patients with HD

By Blystad AK   Torlakovic E   Holte H   Kvaløy S   Lenschow E   Kvalheim G  

Cytotherapy, Vol. 3, Iss. 4, 2001-07 ,pp. : 295-305

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Improving the efficiency of PBPC collection by pre-apheresis peripheral blood and mid-apheresis product measurements of CD34 cells

By Lane TA   Bashey A   Carrier E   Holman P   Castro J   Mullen M   Ward DM   Ada O   Ball ED  

Cytotherapy, Vol. 6, Iss. 4, 2004-08 ,pp. : 318-327

Ashgate Publishing Ltd

Access to resources Recommend Favorite